PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHICL Infrastructure Regulatory News (HICL)

Share Price Information for HICL Infrastructure (HICL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 123.80
Bid: 123.80
Ask: 124.20
Change: -1.40 (-1.12%)
Spread: 0.40 (0.323%)
Open: 124.40
High: 124.40
Low: 123.20
Prev. Close: 125.20
HICL Live PriceLast checked at -
HICL Infrastructure is an Investment Trust

To deliver a long-term, stable income to shareholders from a diversified portfolio of infrastructure investments positioned at the lower end of the risk spectrum.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

15 Dec 2014 10:00

RNS Number : 6532Z
HICL Infrastructure Company Ld
15 December 2014
 



THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE INCLUDING IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR TO U.S. PERSONS.

15 December 2014

 

HICL Infrastructure Company Limited (the "Company" or "HICL")

 

Issue of equity

 

Introduction

 

The Board of HICL today announces a proposal to raise approximately £25 million through an issue of Ordinary Shares in the capital of the company (the "New Ordinary Shares") by way of tap issuance (the "Issue"). The Issue will be made to qualifying investors* through HICL's corporate broker, Canaccord Genuity Limited ("Canaccord Genuity").

 

Although the Company had not originally envisaged undertaking an equity raising in the near term given the imminent receipt of proceeds from the portfolio investment which it has contracted to sell, certain other investment acquisition opportunities have progressed more rapidly than expected. Against this backdrop the Board deems it prudent to raise equity now to repay some of the drawings under its £150m revolving credit facility to ensure that there is sufficient capacity to finance these new opportunities ahead of receiving the disposal proceeds.

 

Details of the Issue and expected timetable

Under the terms of the Issue, HICL intends to issue up to 17 million Ordinary Shares of 0.01 pence each in the capital of the Company, under authority granted by Shareholders at its Annual General Meeting on 22 July 2014.

 

The Issue will be non pre-emptive and will be launched immediately following this announcement, when Canaccord Genuity will commence a bookbuilding process to determine the level of demand from potential investors for participation in the Issue. The number of New Ordinary Shares to be issued and the price per Share (the "Strike Price") will be agreed between Canaccord Genuity and the Company following close of the bookbuild at noon on Wednesday 17 December, and announced shortly thereafter. Canaccord Genuity and the Company reserve the right to set a maximum percentage of New Ordinary Shares that may be allocated to any one investor.

 

The New Ordinary Shares are not being offered at a fixed price. To bid in the bookbuild, investors should communicate their bid (or bids) by telephone to their usual sales contact at Canaccord Genuity. Each bid should state the number of New Ordinary Shares for which the prospective investor wishes to subscribe and the price or price range that the prospective investor is offering to pay; any bid price must be for a full pence or half pence amount. No more than 17 million New Ordinary Shares will be issued in aggregate. The Strike Price will be in excess of the Company's prevailing net asset value per Ordinary Share.

The bookbuild is expected to close at noon (London time) on 17 December 2014 but may be closed earlier or later at the discretion of the Company and Canaccord Genuity. Canaccord Genuity may, in agreement with the Company, accept bids that are received after the bookbuild has closed.

Subject to the above, Canaccord Genuity may choose to accept bids, either in whole or in part, on the basis of allocations determined in agreement with the Company, and may scale down any bids for this purpose on such basis as the Company and Canaccord Genuity may determine. Canaccord Genuity may also, notwithstanding the above, subject to the prior consent of the Company: (i) allocate New Ordinary Shares after the time of any initial allocation to any person submitting a bid after that time, and (ii) allocate New Ordinary Shares after the bookbuild has closed to any person submitting a bid after that time. The Company reserves the right to reduce the amount to be raised pursuant to the Issue.

Application for listing and admission to trading

Application will be made to the Financial Conduct Authority for admission of the New Ordinary Shares to the premium segment of the Official List of the FCA and to London Stock Exchange plc for admission to trading of the New Ordinary Shares on its main market for listed securities (together, "Admission"). It is expected that Admission will become effective on or around 19 December 2014 and that dealings in the New Ordinary Shares on the London Stock Exchange's main market for listed securities will commence at that time.

 

* As defined in section 86(7) of the Financial Services and Markets Act 2000 (as amended).

For further information, please contact:

InfraRed Capital Partners Limited

 

Tony Roper

Keith Pickard

Robin Hubbard

+44 (0) 20 7484 1800

 

Canaccord Genuity Limited

 

Robbie Robertson

Dominic Waters

Neil Brierley

Will Barnett

Gavin Tooke

David Yovichic

 

 

+44 (0) 20 7523 8000

 

Tulchan Communications

 

Martha Walsh

 

 

+44 (0) 20 7353 4200

 

Dexion Capital (Guernsey) Limited

Carol Kilby

 

+44 (0) 1481 743943

 

 

Important Information

This Announcement has been issued by and is the sole responsibility of the Company.

 

No representation or warranty express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Canaccord Genuity Limited ("Canaccord") or by any of its respective affiliates or agents as to or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

 

Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction.

 

This announcement and the information contained herein is not for publication, release or distribution, directly or indirectly, in or into the United States, Australia, Canada or Japan or any jurisdiction in which the same would be unlawful. This announcement does not constitute an offer to sell or issue or the solicitation of an offer to buy or acquire shares in the capital of the Company in the United States, Australia, Canada or Japan or any jurisdiction in which such an offer or solicitation is unlawful.

 

Shares in HICL have not been, nor will be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or with any securities regulatory authority of any State or other jurisdiction of the United States, and accordingly may not be offered, sold or transferred within the United States except pursuant to an exemption from, or in a transaction not subject to, registration under the Securities Act. No offering of the Shares is being made in the United States or to U.S. persons as defined in and in accordance with Regulation S under the Securities Act ("U.S. Persons"). The Company has not been and will not be registered under the U.S. Investment Company Act of 1940, as amended (the "Investment Company Act") and investors will not be entitled to the benefits of that Act.

 

Canaccord Genuity Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting for HICL Infrastructure Company Limited and is acting for no-one else in connection with the Issue.

 

InfraRed Capital Partners Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, acts as Investment Adviser to HICL Infrastructure Company Limited and is acting for no-one else in connection with the Issue.

 

This Announcement is for information purposes only and does not constitute an invitation to subscribe for or otherwise acquire or dispose of securities in the Company in any jurisdiction. The information contained in this Announcement is for background purposes only and does not purport to be full or complete. This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase any investments nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEXLLFFZLFBFBD
Date   Source Headline
30th Nov 201512:00 pmRNSHolding(s) in Company
30th Nov 20157:00 amRNSPublication of Interim Report
18th Nov 20157:00 amRNSINTERIM RESULTS SIX MONTHS ENDED 30 SEPTEMBER 2015
12th Nov 20159:21 amRNSSecond Quarterly Interim Dividend
11th Nov 20158:32 amRNSDirector Declaration
26th Oct 20159:40 amRNSDirector Declaration
12th Oct 20158:02 amRNSNotice of Interim Results
7th Oct 20154:00 pmRNSDirector/PDMR Shareholding
1st Oct 20158:18 amRNSCompletion of Acquisition and Partial Disposal
30th Sep 201512:07 pmRNSTotal Voting Rights
21st Sep 20157:00 amRNSAdditional Listing
8th Sep 201511:45 amRNSScrip Share Reference Price
12th Aug 20155:00 pmRNSResult of EGM
7th Aug 201511:50 amRNSDirector Declaration
31st Jul 201510:56 amRNSTotal Voting Rights
30th Jul 20157:00 amRNSIssue of Ordinary Shares
27th Jul 20157:00 amRNSIssue of Equity
24th Jul 20157:30 amRNSQuarterly Update Statement
24th Jul 20157:00 amRNSChairman and Senior Independent Director
22nd Jul 20159:44 amRNSFirst Quarterly Interim Dividend
21st Jul 20154:48 pmRNSResult of AGM - Replacement
21st Jul 20154:30 pmRNSResult of AGM
17th Jul 20157:00 amRNSEGM for Proposed Acquisition
7th Jul 20157:00 amRNSAcquisition of a new investment
6th Jul 20158:29 amRNSDirector/PDMR Shareholding
30th Jun 201512:22 pmRNSTotal Voting Rights
18th Jun 20154:58 pmRNSAdditional Listing
8th Jun 20155:00 pmRNSDocuments for Inspection - Annual Report & AGM
4th Jun 20153:38 pmRNSScrip Share Reference Price
3rd Jun 201511:05 amRNSHolding(s) in Company
1st Jun 20155:30 pmRNSDirector/PDMR Shareholding
27th May 20154:32 pmRNSDirector/PDMR Shareholding
21st May 20157:00 amRNSAnnual Financial Report
14th May 20151:28 pmRNSDirectorate Change
14th May 201510:15 amRNSDividend Declaration
23rd Apr 20157:00 amRNSDisposal of an Investment
14th Apr 20157:00 amRNSAcquisition of two incremental investments
13th Apr 20157:00 amRNSNotice of Annual Results
10th Apr 20153:37 pmRNSDirector/PDMR Shareholding
1st Apr 20157:00 amRNSNew Investment in Holland
31st Mar 201511:50 amRNSTotal Voting Rights
30th Mar 201510:35 amRNSHolding(s) in Company
25th Mar 20158:23 amRNSDirector/PDMR Shareholding
19th Mar 20155:15 pmRNSAdditional Listing
12th Mar 20157:00 amRNSAcquisition of three new UK schools investments
11th Mar 20157:00 amRNSNew UK Investment
9th Mar 20157:00 amRNSDirector Declaration
5th Mar 201511:08 amRNSScrip Share Reference Price
23rd Feb 20157:00 amRNSQuarterly Update Statement
18th Feb 20152:00 pmRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.